...
首页> 外文期刊>Saudi Pharmaceutical Journal >Formulation and optimization of orodispersible tablets of flutamide
【24h】

Formulation and optimization of orodispersible tablets of flutamide

机译:氟他胺口腔分散片的配制与优化

获取原文

摘要

The present study aimed to formulate orodispersible tablets of flutamide (FTM) to increase its bioavailability. Orodispersible tablets were prepared by direct compression technique using three different approaches namely; super-disintegration, effervescence and sublimation. Different combined approaches were proposed and evaluated to optimize tablet characteristics. Sodium starch glycolate (SSG) was used as the superdisintegrant. The prepared powder mixtures were subjected to both pre and post compression evaluation parameters including; IR spectroscopy, micromeritics properties, tablet hardness, friability, wetting time, disintegration time and in-vitro drug release. IR studies indicated that there was no interaction between the drug and the excipients used except Ludipress. The results of micromeritics studies revealed that all formulations were of acceptable to good flowability. Tablet hardness and friability indicated good mechanical strength. Wetting and dispersion times decreased from 46 to 38s by increasing the SSG concentration from 3.33 to 6.66%w/w in tablets prepared by superdisintegration method. The F8 formulation which was prepared by combined approaches of effervescence and superdisintegrant addition gave promising results for tablet disintegration and wetting times but failed to give faster dissolution rate. The incorporation of 1:5 solid dispersion of FTM: PEG 6000 instead of the pure drug in the same formulation increased the drug release rate from 73.12 to 96.99% after 15min. This increase in the dissolution rate may be due to the amorphization of the drug during the solid dispersion preparation. The presence of the amorphous form of the drug was shown in the IR spectra.
机译:本研究旨在配制氟他胺(FTM)的口腔分散片,以提高其生物利用度。通过直接压片技术使用三种不同的方法制备可口分散片剂。超崩解,泡腾和升华。提出并评估了不同的组合方法以优化片剂特性。淀粉羟乙酸钠(SSG)被用作超崩解剂。对制得的粉末混合物进行压缩前后的评估参数,包括:红外光谱,微商学性质,片剂硬度,易碎性,润湿时间,崩解时间和体外药物释放。 IR研究表明,除Ludipress外,药物与所用赋形剂之间没有相互作用。微观力学研究的结果表明,所有制剂都具有良好的流动性。片剂的硬度和脆性表明良好的机械强度。通过将超崩解方法制备的片剂中的SSG浓度从3.33增加到6.66%w / w,润湿和分散时间从46s减少到38s。通过泡腾和超崩解剂添加相结合的方法制备的F8制剂在片剂崩解和润湿时间方面取得了令人鼓舞的结果,但未能给出更快的溶出速率。在15分钟后,将FTM:PEG 6000的1:5固体分散体代替纯药物掺入同一制剂,可使药物释放率从73.12%增加到96.99%。溶解速率的这种增加可能是由于在固体分散体制备过程中药物的非晶化。红外光谱显示了药物的无定形形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号